• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

Visceral leishmaniasis unresponsive to antimonial drugs. III. Successful treatment using a combination of sodium stibogluconate plus allopurinol.

作者信息

Chunge C N, Gachihi G, Muigai R, Wasunna K, Rashid J R, Chulay J D, Anabwani G, Oster C N, Bryceson A D

出版信息

Trans R Soc Trop Med Hyg. 1985;79(5):715-8. doi: 10.1016/0035-9203(85)90200-7.

DOI:10.1016/0035-9203(85)90200-7
PMID:3006296
Abstract

Five patients with long-standing visceral leishmaniasis who were unresponsive to sodium stibogluconate, 20 mg antimony/kg body-weight once or twice daily, were treated for 14 to 54 days with a combination of sodium stibogluconate at the same dose plus allopurinol at a dose of 20 mg/kg body-weight per day in three divided doses. This combination was safe and effective. Negative splenic aspirate smears were obtained from all patients within 19 days, and none has relapsed in at least 12 months of follow-up.

摘要

相似文献

1
Visceral leishmaniasis unresponsive to antimonial drugs. III. Successful treatment using a combination of sodium stibogluconate plus allopurinol.
Trans R Soc Trop Med Hyg. 1985;79(5):715-8. doi: 10.1016/0035-9203(85)90200-7.
2
Visceral leishmaniasis unresponsive to antimonial drugs. II. Response to high dosage sodium stibogluconate or prolonged treatment with pentamidine.对锑剂无反应的内脏利什曼病。II. 对高剂量葡糖酸锑钠或喷他脒延长治疗的反应
Trans R Soc Trop Med Hyg. 1985;79(5):705-14. doi: 10.1016/0035-9203(85)90199-3.
3
The response of Kenyan kala-azar to treatment with sodium stibogluconate.肯尼亚黑热病对葡萄糖酸锑钠治疗的反应。
Am J Trop Med Hyg. 1984 May;33(3):357-61. doi: 10.4269/ajtmh.1984.33.357.
4
Clinical, haematological and parasitological response to treatment of visceral leishmaniasis in Kenya. A study of 64 patients.
Trop Geogr Med. 1984 Mar;36(1):21-35.
5
A comparative study of allopurinol and pentostam in the treatment of visceral leishmaniasis.别嘌呤醇与喷他脒治疗内脏利什曼病的对比研究。
Adv Exp Med Biol. 1986;195 Pt A:471-3. doi: 10.1007/978-1-4684-5104-7_78.
6
Electron microscopy of Leishmania donovani in splenic aspirates from patients with visceral leishmaniasis during treatment with sodium stibogluconate.在用葡萄糖酸锑钠治疗内脏利什曼病患者期间,对其脾脏穿刺物中的杜氏利什曼原虫进行电子显微镜检查。
Ann Trop Med Parasitol. 1985 Aug;79(4):417-29. doi: 10.1080/00034983.1985.11811940.
7
Successful treatment of visceral leishmaniasis with allopurinol plus ketoconazole in a renal transplant recipient after the occurrence of pancreatitis due to stibogluconate.在一名肾移植受者因葡萄糖酸锑钠引发胰腺炎后,使用别嘌呤醇加酮康唑成功治疗内脏利什曼病。
Clin Infect Dis. 1993 Mar;16(3):397-9. doi: 10.1093/clind/16.3.397.
8
Treatment of visceral leishmaniasis using sodium stibogluconate in a dose of 15 mg antimony/kg body weight twice daily for 30 days: a preliminary report.
East Afr Med J. 1984 Jul;61(7):570-4.
9
High-dose sodium stibogluconate treatment of cutaneous leishmaniasis in Kenya.高剂量葡萄糖酸锑钠治疗肯尼亚皮肤利什曼病
Trans R Soc Trop Med Hyg. 1983;77(5):717-21. doi: 10.1016/0035-9203(83)90213-4.
10
Kala-azar: unresponsiveness to prolonged sodium stibogluconate therapy.黑热病:对延长的葡萄糖酸锑钠治疗无反应。
J Assoc Physicians India. 1987 Jul;35(7):543.

引用本文的文献

1
In Vitro Antileishmanial and Antischistosomal Activities of Anemonin Isolated from the Fresh Leaves of Forsk.从福司考苷叶中分离出的白头翁素的抗利什曼原虫和抗血吸虫活性的体外研究
Molecules. 2021 Dec 10;26(24):7473. doi: 10.3390/molecules26247473.
2
Interventions for Old World cutaneous leishmaniasis.旧世界皮肤利什曼病的干预措施。
Cochrane Database Syst Rev. 2017 Dec 1;12(12):CD005067. doi: 10.1002/14651858.CD005067.pub5.
3
Interventions for Old World cutaneous leishmaniasis.旧世界皮肤利什曼病的干预措施。
Cochrane Database Syst Rev. 2017 Nov 17;11(11):CD005067. doi: 10.1002/14651858.CD005067.pub4.
4
Nanotized Curcumin and Miltefosine, a Potential Combination for Treatment of Experimental Visceral Leishmaniasis.纳米姜黄素与米替福新:治疗实验性内脏利什曼病的潜在联合用药方案
Antimicrob Agents Chemother. 2017 Feb 23;61(3). doi: 10.1128/AAC.01169-16. Print 2017 Mar.
5
Use of antimony in the treatment of leishmaniasis: current status and future directions.锑在利什曼病治疗中的应用:现状与未来方向。
Mol Biol Int. 2011;2011:571242. doi: 10.4061/2011/571242. Epub 2011 Jun 8.
6
Changing pattern of visceral leishmaniasis, United Kingdom, 1985-2004.1985 - 2004年英国内脏利什曼病的变化模式
Emerg Infect Dis. 2006 Aug;12(8):1257-9. doi: 10.3201/eid1708.050486.
7
Drug resistance in leishmaniasis.利什曼病中的耐药性。
Clin Microbiol Rev. 2006 Jan;19(1):111-26. doi: 10.1128/CMR.19.1.111-126.2006.
8
In vitro and in vivo interactions between miltefosine and other antileishmanial drugs.米替福新与其他抗利什曼原虫药物的体外和体内相互作用。
Antimicrob Agents Chemother. 2006 Jan;50(1):73-9. doi: 10.1128/AAC.50.1.73-79.2006.
9
Purine nucleobase transport in amastigotes of Leishmania mexicana: involvement in allopurinol uptake.墨西哥利什曼原虫无鞭毛体中的嘌呤核碱基转运:与别嘌呤醇摄取有关。
Antimicrob Agents Chemother. 2005 Sep;49(9):3682-9. doi: 10.1128/AAC.49.9.3682-3689.2005.
10
Leishmania and human immunodeficiency virus coinfection: the first 10 years.利什曼原虫与人类免疫缺陷病毒合并感染:头十年
Clin Microbiol Rev. 1997 Apr;10(2):298-319. doi: 10.1128/CMR.10.2.298.